ilcocillin ps 200/200 ad us. vet. injizierbare suspension
biokema s.a. - benzylpenicillinum procainum, dihydrostreptomycinum - injizierbare suspension - benzylpenicillinum procainum 200 mg corresp. 200'000 u.i., dihydrostreptomycinum 200 mg ut dihydrostreptomycini sulfas, povidonum k 12, polysorbatum 80, lecithinum, natrii citras dihydricus, dinatrii edetas, procaini hydrochloridum 10 mg, natrii hydroxymethansulfinas 1.25 mg, cetrimidum, e 219 1.12 mg, propylis parahydroxybenzoas natricus 0.164 mg, e 215 0.240 mg, acidum citricum, kalii chloridum, aqua ad iniectabile, ad suspensionem pro 1 ml. - antibiotique pour bovins, ovins, porcins, chiens et chats - synthetika
influvac injektionssuspension
mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/brisbane/02/2018 (h1n1)-like: reassortanten virus a/brisbane/02/2018, ivr-190), haemagglutininum influenzae a (h3n2) (virus-stamm a/kansas/14/2017 (h3n2)-like: reassortanten virus a/kansas/14/2017, nymc x-327), haemagglutininum influenzae b (virus-stamm b/colorado/06/2017-wie: reassortanten virus b/maryland/15/2016 nymc bx-69a) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus-stamm a/brisbane/02/2018 (h1n1)-like: reassortant virus a/brisbane/02/2018, ivr-190) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/kansas/14/2017 (h3n2)-like: reassortant virus a/kansas/14/2017, nymc x-327) 15 µg, haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant virus b/maryland/15/2016 nymc bx-69a) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: natrii citras dihydricus max. 1 mg, cetrimidum max. 15 µg, formaldehydum max. 10 µg, gentamicini sulfas max. 1 ng, tylosini tartras nihil, hydrocortisonum nihil, polysorbatum 80 nihil, ovalbuminum max. 0.1 µg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen influenza, ab dem vollendeten 6. lebensmonat - impfstoffe
fluad injektionssuspension
medius ag - haemagglutininum influenzae a (h1n1), neuraminidasum inactivatum (virus-stamm a/brisbane/02/2018 (h1n1)-like: reassortanten virus ivr-190, abgeleitet von a/brisbane/02/2018), haemagglutininum influenzae a (h3n2), haemagglutininum influenzae b - injektionssuspension - haemagglutininum influenzae a (h1n1) mind.15 µg und neuraminidasum inactivatum (virus-stamm a/brisbane/02/2018 (h1n1)-like: reassortanten virus ivr-190, abgeleitet von a/brisbane/02/2018), haemagglutininum influenzae a (h3n2) mind.15 µg und neuraminidasum inactivatum (virus-stamm a/kansas/14/2017 (h3n2)-like: reassortanten virus x-327, abgeleitet von a/kansas/14/2017), haemagglutininum influenzae b mind.15 µg und neuraminidasum inactivatum (virus-stamm b/colorado/06/2017)-wie: reassortanten viren der b/victoria/2/87_b/maryland/15/2016), adjuvans mf59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acid citricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesium, chloridum hexahydricum, calcium chloridum dihydricum, der rest: ovalbuminum, barii sulfas, kanamycini monosulfas, neomycini sulfas, formaldehydum, cetrimidum, hydrocortisonum, aqua ad iniectabilia q.s. zu der suspension 0,5 ml. - aktive immunisierung gegen influenza für ältere menschen (65 jahre oder älter), besonders für personen mit erhöhtem risiko für influenza-assoziierte komplikationen - impfstoffe
azaron lotion 20 mg/g emulsion zur anwendung auf der haut
omega pharma belgium - diphenhydramin hydrochlorid - emulsion zur anwendung auf der haut - 20 mg/g - diphenhydramin hydrochlorid 20 mg/g - diphenhydramine
vidisic 2 mg/g augengel
bausch & lomb pharma - carbomere - augengel - 2 mg/g - carbomere 2 mg/g - artificial tears and other indifferent preparations
influvac injektionssuspension
mylan pharma gmbh - haemagglutininum influenzae a (h1n1) (virus-stamm a/brisbane/02/2018 (h1n1)-like: reassortanten virus a/brisbane/02/2018, ivr-190), haemagglutininum influenzae a (h3n2) (virus-stamm a/kansas/14/2017 (h3n2)-like: reassortanten virus a/kansas/14/2017, nymc x-327), haemagglutininum influenzae b (virus-stamm b/colorado/06/2017-wie: reassortanten virus b/maryland/15/2016 nymc bx-69a) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus-stamm a/brisbane/02/2018 (h1n1)-like: reassortant virus a/brisbane/02/2018, ivr-190) 15 µg, haemagglutininum influenzae a (h3n2) (virus-stamm a/kansas/14/2017 (h3n2)-like: reassortant virus a/kansas/14/2017, nymc x-327) 15 µg, haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant virus b/maryland/15/2016 nymc bx-69a) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: natrii citras dihydricus max. 1 mg, cetrimidum max. 15 µg, formaldehydum max. 10 µg, gentamicini sulfas max. 1 ng, tylosini tartras nihil, hydrocortisonum nihil, polysorbatum 80 nihil, ovalbuminum max. 0.1 µg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen influenza, ab dem vollendeten 6. lebensmonat - impfstoffe
flucelvax tetra injektionssuspension
medius ag - haemagglutininum influenzae a (h3n2) (virus stamm a/kansas/14/2017 (h3n2)-like: derived from a/indiana/08/2018), haemagglutininum influenzae a (h1n1) (virus stamm a/brisbane/02/2018 (h1n1)-like: derived from a/idaho/07/2018), haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant from b/iowa/06/2017 (victoria lineage)) - injektionssuspension - haemagglutininum influenzae a (h3n2) (virus stamm a/kansas/14/2017 (h3n2)-like: derived from a/indiana/08/2018) 15 µg, haemagglutininum influenzae a (h1n1) (virus stamm a/brisbane/02/2018 (h1n1)-like: derived from a/idaho/07/2018) 15 µg, haemagglutininum influenzae b (virus stamm b/colorado/06/2017-like: reassortant from b/iowa/06/2017 (victoria lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013-like: reassortant from b/singapore/inftt-16-0610/2016 (yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum. - aktive immunisierung gegen influenza , ab 9 jahren - impfstoffe
levocetirizin actavis 5 mg filmtabletten
actavis group ptc ehf. - levocetirizin dihydrochlorid - levocetirizin
lecisyn 5 mg filmtabletten
teva b.v. - levocetirizin dihydrochlorid - levocetirizin
levocetirizin synthon 5 mg filmtabletten
synthon bv - levocetirizin dihydrochlorid - levocetirizin